Leadership

Kevin Taegeun Choi is the CEO and co-founder of Mediwhale, a digital healthcare company leading innovation in preventive care through AI-driven retinal imaging. Under his leadership, Mediwhale became the first to commercialize AI solutions for assessing cardiometabolic and kidney disease risks, with global hospital adoption.

He holds a degree in Industrial and Management Engineering from POSTECH, and is dedicated to advancing early disease detection in primary care by making high-quality health assessments more accessible and actionable.

Tyler Hyungtaek Rim is the CMO and co-founder of Mediwhale, where he leads medical research and clinical strategy for AI-based disease detection. A retina specialist and clinician scientist, he has advanced the use of machine learning in ophthalmology.

Previously, he held academic and clinical roles at Duke-NUS Medical School, SERI, SNEC, and Yonsei University Severance Hospital. He has authored over 150 peer-reviewed papers and holds a B.S. in Chemistry from KAIST and an MD/PhD from Yonsei University College of Medicine.

Geunyoung Lee is the CTO and co-founder of Mediwhale, leading product development for the company’s AI-driven healthcare solutions. A software development expert, he played a key role in building Dr. Noon, Mediwhale’s core diagnostic technology.

He previously won 2nd place in the 2016 Big Data Health & Science Competition hosted by Asan Medical Center, and holds a B.S. in Nuclear Engineering from Seoul National University.

Nina Shin is the Chief Financial Officer of Mediwhale, overseeing business operations and leading strategic growth initiatives across finance, HR, marketing, and business development.

Before joining Mediwhale, she was Head of Operations at Disney+ Korea, where she led the service’s launch and previously held multiple marketing and strategy roles at The Walt Disney Company Korea. Earlier in her career, she was a Global Brand Manager at Unilever Singapore and a management consultant at Oliver Wyman.

She holds an MBA from Harvard Business School and a B.A. in Business Administration from Seoul National University.

James Huh is the Head of University Hospital Department at Mediwhale, leading hospital-focused sales and partnerships to expand AI-powered healthcare solutions in Korea.

With over 20 years of experience in the pharmaceutical and medical device industries, he held leadership roles at Eli Lilly, Johnson & Johnson, CR Bard, and Edwards Lifesciences Korea.

His expertise spans cardiovascular intervention, arrhythmia, medical imaging, and surgical technologies.

He holds an MBA from Sungkyunkwan University and a B.A. in Economics from Kangwon National University.

Jamie Oh is the Head of Korea Business at Mediwhale, leading sales and strategic growth in Korea’s primary care sector, with a focus on clinics.

He brings over 10 years of healthcare industry experience, having held roles at Osstem Implant and Convatec Korea, specializing in market expansion, B2B partnerships, and medical device sales.

Jamie holds an MBA from Sogang Business School and a B.A. in Law from Kyungpook National University.

Justin Kim is the Head of Global Business at Mediwhale, leading international sales and strategic market expansion for the company’s AI-driven healthcare solutions.

With 20 years of experience in global business development within the medical device industry, he has led overseas sales teams and executed localized marketing strategies across multiple regions.

He holds a bachelor’s degree from the University of Portsmouth.